Cellonis Biotechnologies
BEIJING, December 17 - Using a novel stem cell based technology of Cellonis Biotechnologies,
Beijing, a Chinese research/medical team may eliminate a glioma -- brain
cancer -- of a 36 year old Norwegian patient in a hospital in Beijing.